DCGI orders Serum Institute of India to suspend recruitment for Oxford COVID-19 vaccine trials

New Delhi, Sept 12: Drugs Controller General of India (DCGI) has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate in the backdrop of pharma giant AstraZeneca pausing the trials in other countries.

In an order, a copy of which has been accessed by PTI, DCGI Dr V G Somani on Friday also directed Serum Institute of India (SII) to increase the safety monitoring of the subjects already vaccinated as part of the trial, and submit the plan and report.

Samsung Galaxy Z Fold2 to cost Rs 1.5 lakh, pre-booking starts from Sept 14

Kangana Ranaut's fan arrested for threatening Shiv Sena leader

Karnataka adds 9,140 fresh Covid-19 cases, 94 deaths take toll to 7,161

Karnataka Minister warns of action against Kolar-Chikkaballapur DCC Bank

'My NEP' campaign launched in Karnataka by Dy CM

Sept 11 | 446 new covid-19 cases, 7 deaths in DK; 168 cases, 2 deaths in Udupi

Social activist, Arya Samaj leader, former minister Swami Agnivesh passes away at 80

Udupi | 24-year-old girl killed, others critically injured as car jumps divider, rams into power pole

Removal of 48,000 shanties: Ajay Maken moves SC seeking rehab of slum dwellers before eviction

New Delhi, Sept 11: Senior Congress leader Ajay Maken has moved the Supreme Court seeking rehabilitation of the inhabitants of close to 48,000 slum dwellings along the railway tracks in Delhi. On August 31, the Supreme Court had ordered removal of around 48,000 slum dwellings across railway tracks in Delhi within three months and said no political interference will be entertained in the matter.